Concepedia

Riley Plett

RP

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2022

Affiliations

Saskatchewan Cancer Agency(Current)

Riley Plett is an author at Saskatchewan Cancer Agency specializing in signal transduction in cancer, cyclin-dependent kinase 4/6 inhibitors, and molecular oncology.

ORCID

Publications per year

2022–2022

1

Publications

1

Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel

Riley Plett, Paul Mellor, Stephanie Kendall et al. · Scientific Reports · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

1–1 of 1